Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB
NCT05212597
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Aortic Valve Insufficiency
Interventions
DRUG:
Sacubitril-valsartan
DRUG:
Amlodipine-losartan
Sponsor
Samsung Medical Center